DFX Intelligence

Data Factory

VentureFirmpe with venture activity · probableregistered_investment_adviser

Orbimed Capital LLC

Venture Capital

New York, NY

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:0cb31ef9-de5a-4226-b5e4-7638748bda56

Data as of Sep 12, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 4:18 PM UTC and rebuilt at most every 15 minutes.

Relationships: 15
Dated events: 5
On other graphs: 1
Observed: Sep 12, 2026 to Sep 12, 2026
32 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

RIA / Wealth Managementidentity

ORBIMED CAPITAL LLC

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 1
Regulatory AUM: $8.0B
Funds with fundraising evidence: 0derived
Investments: 3
Portfolio companies: 3
Investments, 12m: 3
Partner-attributed: 0
People: 9
Investment professionals: 6derived
Co-investors: 0derived
LP relationships: 0
Stated sectors: ai,healthcare,biotech,medtech,mediaas stated by the firm
Stated stages: growth,early
Stated geography: global,globally,worldwide
Latest ADV filing: Mar 29, 2016
Website: orbimed.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV	LPs
Orbimed Associates LLC	n/a	Wound down	n/a	$109,000	0

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
world	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Telios Pharma Inc	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026
Cookiedatabase	n/a	n/a	n/a	n/a	Unknown	Sep 12, 2026

Relationships

Member of firm (1)

→ Orbimed Advisors LLCFirmSame registered website
inferenceForm ADV

Invested in (3)

→ worldCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ Telios Pharma IncCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site
→ CookiedatabaseCompanyPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site

Employs (10)

→ Jonathan Todd SilversteinPersonMember
Jan 1, 2005 to presentfactForm ADV
→ Geoffrey Che-Chang HsuPersonMember
Jan 1, 2010 to presentfactForm ADV
→ William Carter NeildPersonMember
Jan 1, 2007 to presentfactForm ADV
→ Evan Dean SotiriouPersonChief Financial Officer
Oct 1, 2011 to presentfactForm ADV
→ Douglas W. CoonPersonChief Compliance Officer
Feb 1, 2016 to presentfactForm ADV
→ Alexander Matthew CooperPersonGeneral Counsel
Jul 1, 2010 to presentfactForm ADV
→ Samuel David IsalyPersonManaging Member
Feb 1, 2000 to presentfactForm ADV
→ Sven Heinz BorhoPersonMember
Oct 1, 1998 to presentfactForm ADV
→ Carl Lee GordonPersonMember
Jan 1, 1998 to presentfactForm ADV
→ Michael Bart ShefferyPersonMember
Jan 1, 1998 to Mar 31, 2014inferenceForm ADV

Manages (1)

→ Orbimed Associates LLCFundVenture Capital Fund
Mar 7, 2012 to presentfactForm ADV

Dated events

2 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Feb 1, 2016
Person joined
Douglas W. Coon joined Schedule A of Orbimed Capital LLC as Chief Compliance Officer
Form ADVobserved 7 days ago
Occurred
Mar 31, 2014
Person left
Michael Bart Sheffery (Member) no longer on Schedule A of Orbimed Capital LLC
Form ADVobserved 7 days ago
Occurred
Mar 7, 2012
Adviser's first ADV filing
Orbimed Capital LLC first filed Form ADV (IA)
Form ADVobserved 7 days ago

Show 2 bookkeeping events

Occurred
Mar 29, 2016
Orbimed Associates LLC no longer reported on Form ADV by Orbimed Capital LLC
Occurred
Mar 7, 2012
Orbimed Associates LLC first reported on Form ADV by Orbimed Capital LLC (Venture Capital Fund), GAV $343,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV) · as of 2026-09-12

Also named here, with no published line of their own (reach them through the firm): Jonathan Todd Silverstein (Member), Geoffrey Che-Chang Hsu (Member), William Carter Neild (Member), Evan Dean Sotiriou (Chief Financial Officer), Douglas W. Coon (Chief Compliance Officer), Alexander Matthew Cooper (General Counsel), Samuel David Isaly (Managing Member), Sven Heinz Borho (Member), Carl Lee Gordon (Member).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:0cb31ef9-de5a-4226-b5e4-7638748bda56
First observed: Sep 12, 2026
Last observed: Sep 12, 2026 7 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
2 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Orbimed Capital LLC

Venture Capital

New York, NY

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:0cb31ef9-de5a-4226-b5e4-7638748bda56

Data as of Sep 12, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 4:18 PM UTC and rebuilt at most every 15 minutes.

Fund

Vintage

Lifecycle

Form D sold

GAV

LPs

Orbimed Associates LLC

n/a

Wound down

n/a

$109,000

Company

State

Stage

Round size

Partner

Attribution

Observed

world

n/a

Unknown

Sep 12, 2026

Telios Pharma Inc

n/a

Unknown

Sep 12, 2026

Cookiedatabase

n/a

Unknown

Sep 12, 2026